World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00446732
Date of registration: 11/03/2007
Primary sponsor: Nanovibronix
Public title: The Use of the UroShield Device in Patients With Indwelling Urinary Catheters CAUTI
Scientific title: Catheter Associated Urinary Tract Infections
Date of first enrolment: March 2007
Target sample size: 200
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00446732
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention  
Countries of recruitment
Israel
Contacts
Name:   Ofer Shenfeld, MD
Address: 
Telephone:
Email:
Affiliation: 
Name:   Ofer Shenfeld, MD
Address: 
Telephone: 972-2-6555560
Email: shenfeld@szmc.org.il
Affiliation: 
Name:   Ofer Shenfeled, MD
Address: 
Telephone:
Email:
Affiliation:  Sharei Zedek
Key inclusion & exclusion criteria

Inclusion Criteria:

- Hospitalized patients age 18 years or older

- Patients requiring or having catheterization for more than 24 hours

- Patient able, agrees and signs the Informed Consent Form

Exclusion Criteria:

- Pregnant or breastfeeding women. Women of child bearing potential will perform a
pregnancy test before inclusion into the study

- Presence of any clinically relevant known urinary tract infection

- Patient with condition who is not expected to survive the study period

- Known HIV positive

- Patient has any condition, which precludes compliance with study and/or device
instructions.

- Patient is currently participating in another clinical study.

- Known allergy to latex



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Urinary Tract Infection
Intervention(s)
Device: UroSshield
Primary Outcome(s)
primary end points [Time Frame: up to 14 days]
Secondary Outcome(s)
Secondary ID(s)
US-71-003
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Shaare Zedek Medical Center
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history